As Alzheimer's disease (AD) clinical trials are conducted earlier in the disease continuum, efficient approaches to identify appropriate participants are increasingly important. While biomarkers remain essential for confirming underlying AD pathology, large-scale recruitment efforts require practical methods to identify individuals most likely to meet study clinical eligibility criteria.
Digital cognitive assessments offer a scalable and flexible approach to case finding for site- and community-based recruitment settings, as well as for remote use. Real-time scoring, centralized decision-making and remote administration capabilities enable cognitive data to be incorporated into screening workflows, helping researchers identify individuals who are more likely to demonstrate cognitive impairment, be at elevated risk of progression or exhibit biomarker evidence of AD pathology. However, optimal case finding using digital cognitive assessments requires clearly defined and broadly understood decision-making criteria and recommended actions.
This webinar will review key considerations for designing cognitive pre-screening strategies used in clinical trials of preclinical and symptomatic AD. Drawing on examples from clinical trial and observational research, the featured speaker will discuss how digital cognitive assessments can support recruitment efficiency, the characteristics that make cognitive measures suitable for case-finding applications, the conditions necessary for optimal decision making and evidence supporting the use of digital cognitive assessments in participant identification and enrichment strategies.
Register for this webinar to learn how digital cognitive assessments can support effective pre-screening strategies, improve participant identification and enhance recruitment efficiency in early Alzheimer's disease clinical trials.
Who Should Attend
This webinar will appeal to Executives, Directors, Scientists and Managers from pharmaceutical, biotechnology, CRO and healthcare organizations involved in:
Clinical Development
Clinical Science
Neuroscience and Alzheimer's Disease Research
Clinical Operations
Patient Recruitment and Retention
Clinical Trial Innovation
Digital Health and Decentralized Trials
Biomarker and Endpoint Strategy
Register free on Xtalks: https://xtalks.com/webinars/digital-cognitive-assessments-for-early-alzheimers-clinical-trials/
